ESSEX INVESTMENT MANAGEMENT CO LLC - CNS PHARMACEUTICALS INC ownership

CNS PHARMACEUTICALS INC's ticker is CNSP and the CUSIP is 18978H102. A total of 13 filers reported holding CNS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
ESSEX INVESTMENT MANAGEMENT CO LLC ownership history of CNS PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2021$142,000
+30.3%
59,565
-2.8%
0.02%
+21.4%
Q4 2020$109,000
+0.9%
61,307
-0.4%
0.01%
-6.7%
Q3 2020$108,000
-28.9%
61,563
-13.5%
0.02%
-40.0%
Q2 2020$152,000
+1.3%
71,148
-0.5%
0.02%
-16.7%
Q1 2020$150,000
-51.0%
71,494
-7.7%
0.03%
-21.1%
Q4 2019$306,00077,4580.04%
Other shareholders
CNS PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Altium Capital Management LP 534,148$951,0000.36%
CVI Holdings, LLC 415,652$740,0000.14%
ESSEX INVESTMENT MANAGEMENT CO LLC 61,307$109,0000.01%
Warberg Asset Management LLC 14,000$25,0000.01%
Alpha Cubed Investments, LLC 10,000$18,0000.00%
Integrated Advisors Network LLC 10,700$19,0000.00%
Core Wealth Advisors, Inc. 550$1,0000.00%
OSAIC HOLDINGS, INC. 5,000$9,0000.00%
WELLS FARGO & COMPANY/MN 41$00.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of CNS PHARMACEUTICALS INC shareholders